SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Campbell KB, Mando JD, Gray AL, Robinson E. Pharmacotherapy 2007; 27(3): 459-463.

Copyright

(Copyright © 2007, Pharmacotherapy Publications)

DOI

10.1592/phco.27.3.459

PMID

17316157

Abstract

Dofetilide, a class III antiarrhythmic agent, is prescribed for conversion to and maintenance of normal sinus rhythm in patients with persistent atrial fibrillation or atrial flutter. Most antiarrhythmics have significant toxicities such as torsade de pointes, and patients should be closely monitored while receiving antiarrhythmic therapy. However, we know of no reports concerning management of intentional overdose of dofetilide that have been published. We report the case of a 33-year-old man who was treated for ingestion of approximately 5 mg of dofetilide as a suicide attempt. In addition, he had a known history of cocaine abuse. He came to the emergency department approximately 45 minutes after the ingestion; examination revealed a QTc interval of approximately 570 msec. He was treated with activated charcoal and sorbitol by nasogastric tube and received aggressive supplementation with potassium and magnesium. The patient was monitored by telemetry for several days and responded well. Cardiac toxicity is the utmost concern when treating dofetilide overdose. The mainstay of treatment focuses on supportive care and prevention of drug absorption. Ventricular dysrhythmias or torsade de pointes should be treated according to advanced cardiac life support guidelines.


Language: en

Keywords

Adult; Anti-Arrhythmia Agents; Charcoal; Cocaine-Related Disorders; Drug Monitoring; Drug Overdose; Emergency Service, Hospital; Emergency Treatment; Humans; Male; Phenethylamines; Sorbitol; Suicide, Attempted; Sulfonamides

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print